• Live Feeds
    • Press Releases
    • Insider Trading
    • FDA Approvals
    • Analyst Ratings
    • Insider Trading
    • SEC filings
    • Market insights
  • Analyst Ratings
  • Alerts
  • Subscriptions
  • Settings
  • RSS Feeds
Quantisnow Logo
  • Live Feeds
    • Press Releases
    • Insider Trading
    • FDA Approvals
    • Analyst Ratings
    • Insider Trading
    • SEC filings
    • Market insights
  • Analyst Ratings
  • Alerts
  • Subscriptions
  • Settings
  • RSS Feeds
PublishDashboard
    Quantisnow Logo

    © 2025 quantisnow.com
    Democratizing insights since 2022

    Services
    Live news feedsRSS FeedsAlertsPublish with Us
    Company
    AboutQuantisnow PlusContactJobsAI employees
    Legal
    Terms of usePrivacy policyCookie policy

    Chase Corporation Announces Fiscal Second Quarter 2023 Results

    4/6/23 4:58:00 PM ET
    $CCF
    Building Products
    Consumer Discretionary
    Get the next $CCF alert in real time by email

    Quarterly Revenue Increased 27.5% Year-Over-Year

    Increase in Gross Margin and Free Cash Flow drive debt reduction

    Disciplined Company-wide inventory reduction plan progressing given improved supply chain conditions

    Customer de-stocking initiatives impacting sales

    Chase Corporation (NYSE:CCF), a global specialty chemicals company that is a leading manufacturer of protective materials for high-reliability applications across diverse market sectors, today announced financial results for the second fiscal quarter ended February 28, 2023.

    Fiscal Second Quarter and Year-to-Date Financial and Recent Operational Highlights

    • Total Revenue grew 27.5% to $94.3 million, and 32.4% to $197.2 million, in the second quarter and first six-months of fiscal 2023, respectively
    • Gross Margin of 36.8% (39.7% excluding our NuCera business) in the second quarter of fiscal 2023, compared to 36.6% in the second quarter of fiscal 2022; Gross Margin of 35.8% (39.2% excluding our NuCera business) in the first six-months of fiscal 2023, compared to 36.8% in the first-six months of fiscal 2022
    • Net Income was $8.5 million, or $0.89 per diluted share, compared to $9.1 million, or $0.96 per diluted share in the second quarter of fiscal 2022, – with the reduction primarily due to additional $3.1 million ($0.29 per diluted share) incremental amortization expense related to the NuCera business
    • Free Cash Flow was $10.0 million and $14.7 million in the second quarter and first-six months of fiscal 2023, respectively, compared to Free Cash Flow of $1.6 million and $7.0 million in the second quarter and first-six months of fiscal 2022, respectively
    • Adjusted EBITDA grew 31.4% to $22.0 million and 36.9% to $47.2 million in the second quarter and first-six months of fiscal 2023, respectively, compared to Adjusted EBITDA of $16.8 million and $34.5 million in the second quarter and first-six months of fiscal 2022, respectively

    Adam P. Chase, President and Chief Executive Officer of Chase Corporation, said, "Despite the historical second quarter unfavorable seasonal impact on revenue compared to our first fiscal quarter, the Company saw increased inorganic growth with our NuCera business and increased revenue from our Industrial Tapes segment's specialty products and cable materials product lines compared to our prior year second fiscal quarter."

    Mr. Chase continued, "Consistent with historical patterns, the Company has been impacted by plant shutdowns in Asia due to the Chinese Lunar New Year affecting sales in our Adhesives, Sealants and Additives segment and Industrial Tapes segment's electronic materials product line compared to our first fiscal quarter which contribute to softening sales in both product line's Asia-focused markets. Additionally, the Company's revenue has been impacted by customer de-stocking initiatives affecting all business segments due to improved supply chain conditions."

    Mr. Chase added, "Our previously announced inventory reduction plan realized results in the second quarter. This disciplined approach has allowed the Company to make subsequent payments on our Long-Term Debt and improve cash flow. Additionally, we are striving towards relative inventory to pre-pandemic levels." Mr. Chase, then continued, "As part of our ongoing consolidation and optimization initiative, we have substantially completed the relocation of the Company's Adhesives, Sealants and Additives product lines from Woburn, MA to our O'Hara Township, PA location."

    Mr. Chase concluded, "The previously announced ERP upgrade to the Oracle Fusion Cloud Platform is progressing well and the upgrade will position us to enhance our business with a more advanced system that will support business expansion and functionality. Chase's continued commitment to its customers and financial stability would not be possible without the dedicated work of our employees."

    Michael J. Bourque, Chase Corporation's Treasurer and Chief Financial Officer, stated, "We are pleased with the increased inorganic revenue contributions from our NuCera Business with its integration within our Adhesives, Sealants and Additives segment, expanded end markets, customer base reach, and overall product portfolio. As a result of the NuCera acquisition, several purchase accounting adjustments that included incremental depreciation and amortization as well as additional interest expense related to our Long-Term Debt impacted our bottom line compared to the prior fiscal year. However, we are pleased with the increased EBITDA in the second quarter and year-to-date fiscal period over the comparable prior periods."

    Mr. Bourque concluded, "Our disciplined approach and progress made in our inventory reduction initiatives given the stabilization of the macro-economic environment has allowed us to make $35 million in payments on our revolver debt and has increased our revolving debt facility availability to $155 million. Our balance sheet remains healthy with $36.4 million of cash and a current ratio of 4.8 as of February 28, 2023. As such, Chase remains well positioned to continue paying down debt with free cash flow generation and allows us to invest in key strategic and operational initiatives."

    Segment Results

    Adhesives, Sealants and Additives

     

     

     

     

     

     

     

     

     

     

     

     

     

     

     

    Three Months Ended February 28,

     

    Six Months Ended February 28,

     

     

    2023

     

    2022

     

    2023

     

    2022

    Revenue

     

    $

    48,734

     

    $

    31,780

     

    $

    104,287

     

    $

    62,829

    Cost of products and services sold

     

     

    30,769

     

     

    19,838

     

     

    67,001

     

     

    38,755

    Gross Margin

     

    $

    17,965

     

    $

    11,942

     

    $

    37,286

     

    $

    24,074

    Gross Margin %

     

     

    37%

     

     

    38%

     

     

    36%

     

     

    38%

    Revenue for our Adhesives, Sealants and Additives segment increased in the second quarter and year-to-date periods against the comparable prior year periods. The segment revenue increased $17.0 million, or 53% and $41.5 million, or 66% in the current quarter and year-to-date period, respectively. The second quarter and year-to-date revenue increase was predominately due to the inorganic growth from our NuCera business acquired on the first day of fiscal 2023. The remaining revenue increase for the second fiscal quarter and first six-months of the fiscal period was primarily attributed to sales price increases realized over the comparable prior periods and increased demand for our world-wide focused electronic and industrial coatings product line, totaling $1.5 million and $3.4 million in the second quarter and first half of fiscal 2023. Partially offsetting this increase in revenue in the second fiscal quarter was a reduction in revenue in our organic functional additives product line due to decreased customer demand in North America over the comparable prior fiscal quarter, totaling $1.9 million. However, our organic functional additives product line continues to experience a year-to-date increase in sales over the prior comparable period.

    Industrial Tapes

     

     

     

     

     

     

     

     

     

     

     

     

     

     

     

    Three Months Ended February 28,

     

    Six Months Ended February 28,

     

     

    2023

     

    2022

     

    2023

     

    2022

    Revenue

     

    $

    36,983

     

    $

    33,330

     

    $

    76,060

     

    $

    66,091

    Cost of products and services sold

     

     

    23,477

     

     

    21,790

     

     

    49,196

     

     

    44,009

    Gross Margin

     

    $

    13,506

     

    $

    11,540

     

    $

    26,864

     

    $

    22,082

    Gross Margin %

     

     

    37%

     

     

    35%

     

     

    35%

     

     

    33%

    Revenue for our Industrial Tapes segment surpassed the prior year quarter and year-to-date periods against the comparable prior year periods. The segment revenue increased $3.7 million, or 11% and $10.0 million, or 15% in the current quarter and year-to-date period, respectively. Positively impacting sales for the current quarter and year-to-date period was attributed to sales price increases realized over the prior year periods and increased demand for our North American-focused cable materials and specialty products line, totaling $4.5 million and $10.7 million in the second quarter and year-to-date period, respectively. Partially offsetting the overall increase in the second quarter revenue was a reduction in sales volume in our North American-focused pulling and detection product line, totaling $427,000. However, our pulling and detection product line continues to experience a year-to-date increase in sales over the prior comparable period. Tempering the overall increase in revenue for the segment was second quarter and year-to-date reduction in sales volume from our Asia-focused electronic materials product line, totaling $393,000 and $834,000 in the current quarter and year-to-date period, respectively.

    Corrosion Protection and Waterproofing

     

     

     

     

     

     

     

     

     

     

     

     

     

     

     

    Three Months Ended February 28,

     

    Six Months Ended February 28,

     

     

    2023

     

    2022

     

    2023

     

    2022

    Revenue

     

    $

    8,563

     

    $

    8,843

     

    $

    16,826

     

    $

    20,043

    Cost of products and services sold

     

     

    5,375

     

     

    5,283

     

     

    10,424

     

     

    11,428

    Gross Margin

     

    $

    3,188

     

    $

    3,560

     

    $

    6,402

     

    $

    8,615

    Gross Margin %

     

     

    37%

     

     

    40%

     

     

    38%

     

     

    43%

    Revenue in the Company's Corrosion Protection and Waterproofing segment decreased in the current quarter and year-to-date period against the comparable prior year periods. The segment revenue decreased $280,000, or 3% and $3.2 million, or 16% in the current quarter and year-to-date period, respectively. Negatively impacting sales for the segment was a reduction in sales volume for our building envelope product lines over the comparable prior year periods attributed to customer destocking over the comparable period, totaling $1.3 million and $2.6 million in the current quarter and year-to-date period, respectively. Tempering the overall decrease in revenue for the second quarter and year-to-date period was the commencement of delayed projects in the Middle East market coupled with a demand increase that drove sales gains in North American oil and gas markets, totaling $448,000 and $83,000 in the second quarter and year-to-date period, respectively. Tempering the overall decrease in revenue for the second quarter was an increase in sales volume in our coatings and lining systems, totaling $474,000 in the second fiscal quarter. However, our coatings and lining systems product line continues to experience a year-to-date decrease in sales over the prior year comparable period due to prior year excess demand in the prior first quarter from customer inventory increase initiatives due to reactions of supply chain shortages, totaling $972,000 in the year-to-date fiscal period. Tempering the overall decrease in the second quarter and year-to-date segment revenue was an increase in quarter-to-quarter and year-to-date sales in our bridge and highway projects in North America.

    About Chase Corporation

    Chase Corporation, a global specialty chemicals company that was founded in 1946, is a leading manufacturer of protective materials for high-reliability applications throughout the world. More information can be found on our website https://chasecorp.com/

    Use of Non-GAAP Financial Measures

    The Company has used non-GAAP financial measures in this press release. Adjusted net income, Adjusted diluted EPS, EBITDA, Adjusted EBITDA and Free cash flow are non-GAAP financial measures. The Company believes that Adjusted net income, Adjusted diluted EPS, EBITDA, Adjusted EBITDA and Free cash flow are useful performance measures as they are used by its executive management team to measure operating performance, to allocate resources to enhance the financial performance of its business, to evaluate the effectiveness of its business strategies and to communicate with its board of directors and investors concerning its financial performance. The Company believes Adjusted net income, Adjusted diluted EPS, EBITDA, Adjusted EBITDA and Free cash flow are commonly used by financial analysts and others in the industries in which the Company operates, and thus provide useful information to investors. However, Chase's calculation of Adjusted net income, Adjusted diluted EPS, EBITDA, Adjusted EBITDA and Free cash flow may not be comparable to similarly-titled measures published by others. Non-GAAP financial measures should be considered in addition to, and not as an alternative to, the Company's reported results prepared in accordance with GAAP. This press release provides reconciliations from the most directly comparable financial measure presented in accordance with U.S. GAAP to each non-GAAP financial measure.

    Cautionary Note Concerning Forward-Looking Statements

    Certain statements in this press release are forward-looking. These may be identified by the use of forward-looking words or phrases including, but not limited to, "believe," "expect," "anticipate," "should," "planned," "estimated" and "potential." These forward-looking statements are based on Chase Corporation's current expectations. The Private Securities Litigation Reform Act of 1995 provides a "safe harbor" for such forward-looking statements. To comply with the terms of the safe harbor, the Company cautions investors that any forward-looking statements made by the Company are not guarantees of future performance and that a variety of factors could cause the Company's actual results and experience to differ materially from the anticipated results or other expectations expressed in the Company's forward-looking statements. The risks and uncertainties which may affect the operations, performance, development and results of the Company's business include, but are not limited to, the following: uncertainties relating to economic conditions; uncertainties relating to customer plans and commitments; the pricing and availability of equipment, materials and inventories; technological developments; performance issues with suppliers and subcontractors; economic growth; delays in testing of new products; the Company's ability to successfully integrate acquired operations; the effectiveness of cost-reduction plans; rapid technology changes; the highly competitive environment in which the Company operates; as well as expected impact of the coronavirus disease (COVID-19) pandemic on the Company's businesses. Investors are cautioned not to place undue reliance on these forward-looking statements, which speak only as of the date the statement was made. The Company does not assume any obligation to update or revise any forward-looking statement made in this release or that may from time to time be made by or on behalf of the Company. Additional information regarding the factors that may cause actual results to differ materially from these forward-looking statements is available in the Company's filings with the Securities and Exchange Commission, including the risks and uncertainties identified in Part I, Item 1A - Risk Factors of the Company's Annual Report on Form 10-K for the year ended August 31, 2022.

    The following table summarizes the Company's unaudited financial results for the three and six months ended February 28, 2023 and 2022.

     

     

     

     

     

     

     

     

     

     

     

     

     

     

     

    Three Months Ended February 28,

     

    Six Months Ended February 28,

    All figures in thousands, except per share figures

     

    2023

     

    2022

     

    2023

     

    2022

    Revenue

     

    $

    94,280

     

     

    $

    73,953

     

     

    $

    197,173

     

     

    $

    148,963

     

    Costs and Expenses

     

     

     

     

     

     

     

     

     

     

     

     

    Cost of products and services sold

     

     

    59,621

     

     

     

    46,911

     

     

     

    126,621

     

     

     

    94,192

     

    Selling, general and administrative expenses

     

     

    18,436

     

     

     

    13,125

     

     

     

    40,043

     

     

     

    26,500

     

    Research and product development costs

     

     

    1,463

     

     

     

    1,095

     

     

     

    2,954

     

     

     

    2,088

     

    Operations optimization costs

     

     

    638

     

     

     

    589

     

     

     

    1,291

     

     

     

    648

     

    Acquisition-related costs

     

     

    —

     

     

     

    —

     

     

     

    29

     

     

     

    —

     

    Loss on impairment/write-off of right-of-use lease asset

     

     

    314

     

     

     

    —

     

     

     

    862

     

     

     

    —

     

    Loss (Gain) on contingent consideration

     

     

    128

     

     

     

    (200

    )

     

     

    434

     

     

     

    275

     

    Operating income

     

     

    13,680

     

     

     

    12,433

     

     

     

    24,939

     

     

     

    25,260

     

    Interest expense

     

     

    (2,387

    )

     

     

    (86

    )

     

     

    (4,525

    )

     

     

    (173

    )

    Other income (expense)

     

     

    (301

    )

     

     

    20

     

     

     

    (822

    )

     

     

    397

     

    Income before income taxes

     

     

    10,992

     

     

     

    12,367

     

     

     

    19,592

     

     

     

    25,484

     

    Income taxes

     

     

    2,489

     

     

     

    3,241

     

     

     

    4,365

     

     

     

    6,631

     

    Net income

     

    $

    8,503

     

     

    $

    9,126

     

     

    $

    15,227

     

     

    $

    18,853

     

    Net income per diluted share

     

    $

    0.89

     

     

    $

    0.96

     

     

    $

    1.60

     

     

    $

    1.98

     

    Weighted average diluted shares outstanding

     

     

    9,445

     

     

     

    9,436

     

     

     

    9,444

     

     

     

    9,437

     

    Reconciliation of net income to EBITDA and adjusted EBITDA

     

     

     

     

     

     

     

     

     

     

     

     

    Net income

     

    $

    8,503

     

     

    $

    9,126

     

     

    $

    15,227

     

     

    $

    18,853

     

    Interest expense

     

     

    2,387

     

     

     

    86

     

     

     

    4,525

     

     

     

    173

     

    Income taxes

     

     

    2,489

     

     

     

    3,241

     

     

     

    4,365

     

     

     

    6,631

     

    Depreciation expense

     

     

    2,206

     

     

     

    899

     

     

     

    4,536

     

     

     

    1,776

     

    Amortization expense

     

     

    5,380

     

     

     

    3,042

     

     

     

    13,780

     

     

     

    6,167

     

    EBITDA

     

    $

    20,965

     

     

    $

    16,394

     

     

    $

    42,433

     

     

    $

    33,600

     

    Loss (Gain) on contingent consideration

     

     

    128

     

     

     

    (200

    )

     

     

    434

     

     

     

    275

     

    Operations optimization costs

     

     

    638

     

     

     

    589

     

     

     

    1,291

     

     

     

    648

     

    Acquisition-related costs

     

     

    —

     

     

     

    —

     

     

     

    29

     

     

     

    —

     

    Purchase accounting adjustments

     

     

    —

     

     

     

    —

     

     

     

    2,200

     

     

     

    —

     

    Loss on impairment/write-off of right-of-use lease asset

     

     

    314

     

     

     

    —

     

     

     

    862

     

     

     

    —

     

    Adjusted EBITDA

     

    $

    22,045

     

     

    $

    16,783

     

     

    $

    47,249

     

     

    $

    34,523

     

     

     

     

     

     

     

     

     

     

     

     

     

     

     

     

     

     

     

     

     

     

     

     

     

     

     

     

     

    Three Months Ended February 28,

     

    Six Months Ended February 28,

     

     

    2023

     

    2022

     

    2023

     

    2022

    Reconciliation of net income to adjusted net income

     

     

     

     

     

     

     

     

     

     

     

     

    Net income

     

    $

    8,503

     

     

    $

    9,126

     

     

    $

    15,227

     

     

    $

    18,853

     

    Stock based compensation excess tax loss (gain)

     

     

    10

     

     

     

    10

     

     

     

    (131

    )

     

     

    10

     

    Loss on contingent consideration

     

     

    128

     

     

     

    (200

    )

     

     

    434

     

     

     

    275

     

    Operations optimization costs

     

     

    638

     

     

     

    589

     

     

     

    1,291

     

     

     

    648

     

    Acquisition-related costs

     

     

    —

     

     

     

    —

     

     

     

    29

     

     

     

    —

     

    Purchase accounting adjustments

     

     

    —

     

     

     

    —

     

     

     

    2,200

     

     

     

    —

     

    Loss on impairment/write-off of right-of-use lease asset

     

     

    314

     

     

     

    —

     

     

     

    862

     

     

     

    —

     

    Income taxes *

     

     

    (227

    )

     

     

    (82

    )

     

     

    (1,011

    )

     

     

    (194

    )

    Adjusted net income

     

    $

    9,366

     

     

    $

    9,443

     

     

    $

    18,901

     

     

    $

    19,592

     

    Adjusted net income per diluted share (Adjusted diluted EPS)

     

    $

    0.98

     

     

    $

    0.99

     

     

    $

    1.98

     

     

    $

    2.06

     

     

     

     

     

     

     

     

     

     

     

     

     

     

    * For the three and six months ended February 28, 2023 and 2022, represents the aggregate tax effect assuming a 21% tax rate for the items impacting pre-tax income, which is our effective U.S. statutory Federal tax rate for fiscal 2023 and 2022.

     

     

     

     

     

     

     

     

     

     

     

     

     

     

     

    Three Months Ended February 28,

     

    Six Months Ended February 28,

     

     

    2023

     

    2022

     

    2023

     

    2022

    Reconciliation of cash provided by operating activities to free cash flow

     

     

     

     

     

     

     

     

     

     

     

     

    Net cash provided by operating activities

     

    $

    12,433

     

     

    $

    2,854

     

     

    $

    19,191

     

     

    $

    8,757

     

    Purchases of property, plant and equipment

     

     

    (2,408

    )

     

     

    (1,273

    )

     

     

    (4,460

    )

     

     

    (1,769

    )

    Free cash flow

     

    $

    10,025

     

     

    $

    1,581

     

     

    $

    14,731

     

     

    $

    6,988

     

     

    View source version on businesswire.com: https://www.businesswire.com/news/home/20230406005738/en/

    Get the next $CCF alert in real time by email

    Chat with this insight

    Save time and jump to the most important pieces.

    Recent Analyst Ratings for
    $CCF

    DatePrice TargetRatingAnalyst
    More analyst ratings

    $CCF
    Press Releases

    Fastest customizable press release news feed in the world

    See more
    • Inogen Names Michael Bourque as New Chief Financial Officer

      Inogen, Inc. (NASDAQ:INGN), a medical technology company offering innovative respiratory products for use in the homecare setting, today announced the appointment of Michael Bourque as Chief Financial Officer, effective March 4, 2024. Mr. Bourque has served as Treasurer and Chief Financial Officer of Chase Corporation (NYSE:CCF) now owned by KKR & Co. Inc. He succeeds Interim Chief Financial Officer Mike Sergesketter, who will remain in an advisory role during the transition. Mr. Bourque has served as Chief Financial Officer and Treasurer of Chase Corporation since 2021. He also served as Chief Financial Officer of Keystone Dental, Senior Vice President, Chief Financial Officer and Treasu

      1/24/24 4:00:00 PM ET
      $CCF
      $INGN
      Building Products
      Consumer Discretionary
      Industrial Specialties
      Health Care
    • Chase Corporation Announces Completion of Acquisition by KKR and Welcomes Lance Reisman as Chairman of the Board of Directors

      Chase Corporation ("Chase" or the "Company"), a leading global manufacturer of protective materials for high-reliability applications across diverse market sectors, today announced the successful completion of its acquisition by affiliates of KKR, a leading global investment firm, for $127.50 per share. As a result of the completion of the transaction, Chase common stock has ceased trading and will no longer be listed on the NYSE American. "Today represents an important milestone for Chase in our journey to better serve our customers through strategic growth and innovation," said Adam Chase, President and Chief Executive Officer of Chase. "From the beginning, KKR was a strong cultural fit

      11/15/23 9:23:00 AM ET
      $CCF
      $KKR
      Building Products
      Consumer Discretionary
      Investment Managers
      Finance
    • Chase Corporation Announces October 6, 2023 Special Meeting Results

      Chase Corporation ("Chase" or the "Company") (NYSE:CCF), a leading global manufacturer of protective materials for high-reliability applications across diverse market sectors, held a special meeting of shareholders earlier today (the "Special Meeting") at which Chase shareholders approved the transactions contemplated by that certain Agreement and Plan of Merger (the "Merger Agreement") dated July 21, 2023 by and among Chase, Formulations Parent Corporation ("Parent") and Formulations Merger Sub Corporation ("Merger Sub"). Pursuant to the Merger Agreement, Merger Sub will merge with and into Chase, with Chase surviving as a wholly owned subsidiary of Parent (the "Merger"). Parent and Merger

      10/6/23 4:18:00 PM ET
      $CCF
      $KKR
      Building Products
      Consumer Discretionary
      Investment Managers
      Finance

    $CCF
    Insider Trading

    Insider transactions reveal critical sentiment about the company from key stakeholders. See them live in this feed.

    See more
    • Bourque Michael J. returned 9,738 units of Chase Corporation Common Stock to the company, closing all direct ownership in the company (SEC Form 4)

      4 - CHASE CORP (0000830524) (Issuer)

      11/15/23 7:25:46 PM ET
      $CCF
      Building Products
      Consumer Discretionary
    • Debyle Thomas D. returned 3,886 units of Chase Corporation Common Stock to the company, closing all direct ownership in the company (SEC Form 4)

      4 - CHASE CORP (0000830524) (Issuer)

      11/15/23 7:22:37 PM ET
      $CCF
      Building Products
      Consumer Discretionary
    • Chase Peter R returned 840,519 units of Chase Corporation Common Stock to the company, closing all direct ownership in the company (SEC Form 4)

      4 - CHASE CORP (0000830524) (Issuer)

      11/15/23 7:20:32 PM ET
      $CCF
      Building Products
      Consumer Discretionary

    $CCF
    SEC Filings

    See more
    • SEC Form 15-12G filed by Chase Corporation

      15-12G - CHASE CORP (0000830524) (Filer)

      11/27/23 6:01:05 AM ET
      $CCF
      Building Products
      Consumer Discretionary
    • SEC Form EFFECT filed by Chase Corporation

      EFFECT - CHASE CORP (0000830524) (Filer)

      11/17/23 12:15:07 AM ET
      $CCF
      Building Products
      Consumer Discretionary
    • SEC Form S-8 POS filed by Chase Corporation

      S-8 POS - CHASE CORP (0000830524) (Filer)

      11/15/23 5:23:59 PM ET
      $CCF
      Building Products
      Consumer Discretionary

    $CCF
    Leadership Updates

    Live Leadership Updates

    See more
    • Inogen Names Michael Bourque as New Chief Financial Officer

      Inogen, Inc. (NASDAQ:INGN), a medical technology company offering innovative respiratory products for use in the homecare setting, today announced the appointment of Michael Bourque as Chief Financial Officer, effective March 4, 2024. Mr. Bourque has served as Treasurer and Chief Financial Officer of Chase Corporation (NYSE:CCF) now owned by KKR & Co. Inc. He succeeds Interim Chief Financial Officer Mike Sergesketter, who will remain in an advisory role during the transition. Mr. Bourque has served as Chief Financial Officer and Treasurer of Chase Corporation since 2021. He also served as Chief Financial Officer of Keystone Dental, Senior Vice President, Chief Financial Officer and Treasu

      1/24/24 4:00:00 PM ET
      $CCF
      $INGN
      Building Products
      Consumer Discretionary
      Industrial Specialties
      Health Care
    • Chase Corporation Appoints Ellen Rubin to its Board of Directors

      Chase Corporation (NYSE:CCF), a global specialty chemicals company that is a leading manufacturer of protective materials for high-reliability applications across diverse market sectors, announced on July 14, 2022 that the Board of Directors elected Ellen Rubin to the Board, as an independent director, effective immediately. Additionally, she will serve as a member of Chase's Audit Committee. Peter Chase, Chairman of the Board, commented "We are thrilled to be adding Ellen Rubin's leadership, industry knowledge, and expertise to our Board of Directors as we continue to expand our business, drive scale, and deliver against our proven growth strategy. Ms. Rubin brings to our Board an extensi

      7/20/22 5:23:00 PM ET
      $CCF
      Building Products
      Consumer Discretionary
    • Chase Corporation Announces Fiscal First Quarter 2021 Results

      WESTWOOD, Mass.--(BUSINESS WIRE)--Chase Corporation (NYSE American: CCF), a global specialty chemicals company that is a leading manufacturer of protective materials for high-reliability applications across diverse market sectors, today announced financial results for the quarter ended November 30, 2020, the first quarter of its fiscal year 2021. Fiscal First Quarter Key Highlights Total Revenue of $67.2 million, up compared to $66.8 million in the prior year Gross Margin of 41%, up compared to 37% in the prior year Net Income of $10.8 million, up compared to $7.4 million in the prior year Adjusted EBITDA of $18.1 million, up compared to $14.7 million in the prior year

      1/7/21 4:05:00 PM ET
      $CCF
      Building Products
      Consumer Discretionary

    $CCF
    Financials

    Live finance-specific insights

    See more
    • Chase Corporation Announces Fiscal First Quarter 2023 Results

      Revenue Increased 37.2% to $103 Million Year Over Year NuCera Business Integration Progressing, Elevating Company-Wide Results While Expanding Geographic Footprint and Specialized Product Offerings Chase Corporation (NYSE:CCF), a global specialty chemicals company that is a leading manufacturer of protective materials for high-reliability applications across diverse market sectors, today announced financial results for the first fiscal quarter ended November 30, 2022. Fiscal First Quarter Financial and Recent Operational Highlights Total Revenue grew 37.2% to $103 million, primarily attributed to inorganic growth from the NuCera business which was acquired in the first month of Q1 FY23

      1/5/23 5:01:00 PM ET
      $CCF
      Building Products
      Consumer Discretionary
    • Chase Corporation Announces Fiscal Fourth Quarter 2022 Results

      Revenue Increased by 12.7% to $88 Million in Q4 FY22 compared to Q4 FY21 Gross Margin improved from first half of fiscal 2022 ending the year at 37.8% Declares Dividend of $1.00 Per Share Chase Corporation (NYSE:CCF), a global specialty chemicals company that is a leading manufacturer of protective materials for high-reliability applications across diverse market sectors, announced financial results for the fourth fiscal quarter ended August 31, 2022. The Company also announced a cash dividend of $1.00 per share to shareholders of record on November 30, 2022, payable on December 9, 2022. Fiscal Fourth Quarter Financial and Recent Operational Highlights Total Revenue grew 12.7% to $88

      11/10/22 8:59:00 AM ET
      $CCF
      Building Products
      Consumer Discretionary
    • Chase Corporation Acquires NuCera Solutions

      Transformative acquisition expands the Company's suite of specialty polymers and attractive polymerization technologies, advancing Chase Corp's portfolio of products, customer reach and strategic growth trajectory Chase Corporation (NYSE:CCF), a leading global manufacturer of protective materials for high-reliability applications across diverse market sectors, today announced that it has entered into a definitive agreement to acquire NuCera Solutions, ("NuCera" or the "Company") from SK Capital (a private equity firm headquartered in New York). NuCera is a recognized global leader in the production and development of highly differentiated specialty polymers and polymerization technologies

      7/18/22 6:04:00 PM ET
      $CCF
      Building Products
      Consumer Discretionary

    $CCF
    Large Ownership Changes

    This live feed shows all institutional transactions in real time.

    See more
    • SEC Form SC 13G/A filed by Chase Corporation (Amendment)

      SC 13G/A - CHASE CORP (0000830524) (Subject)

      11/22/23 4:25:56 PM ET
      $CCF
      Building Products
      Consumer Discretionary
    • SEC Form SC 13G/A filed by Chase Corporation (Amendment)

      SC 13G/A - CHASE CORP (0000830524) (Subject)

      9/11/23 8:23:55 AM ET
      $CCF
      Building Products
      Consumer Discretionary
    • SEC Form SC 13G/A filed by Chase Corporation (Amendment)

      SC 13G/A - CHASE CORP (0000830524) (Subject)

      9/8/23 9:17:41 AM ET
      $CCF
      Building Products
      Consumer Discretionary